John Boyer Inc
RANI icon

John Boyer Inc’s Rani Therapeutics RANI Stock Holding History

John Boyer Inc’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$79 Buy
+100
New +$80 ﹤0.01% 227

Other funds holding RANI

SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Kestra Private Wealth Services
Kestra Private Wealth Services Austin, Texas $9.37B AUM 22.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.3B AUM 19.37% 1-Year Est. Return

John Boyer Inc's RANI Position: Q3 2026 in Review

John Boyer Inc opened a new position in Rani Therapeutics (RANI) in Q3 2026: 100 shares worth $79. The stake represents ﹤0.01% of the portfolio and ranks #227 among its holdings.

39 funds tracked by Wall St. Rank hold RANI as of Q3 2026.

  • John Boyer Inc held 100 shares of Rani Therapeutics worth $79 as of Q3 2026.
  • Rani Therapeutics was a new John Boyer Inc position in Q3 2026.
  • Rani Therapeutics made up ﹤0.01% of John Boyer Inc's portfolio in Q3 2026, its #227 holding.
  • 39 funds tracked by Wall St. Rank held Rani Therapeutics as of Q3 2026.

Based on John Boyer Inc's 13F filing for Q3 2026, filed 27 Oct 2026.